Company: BLTE
Filing Date: 2025-10-22
Form Type: F-3ASR
Source: 0001104659-25-101403
Chunk: 5

Company: BELITE BIO, INC
Filing Date: 2025-10-22
Form: F-3ASR
Chunk 5
---
| PLAN OF DISTRIBUTION                                      | ​ | ​ | ​    | ​ | 44 | ​ | ​ |
| WHERE YOU CAN FIND MORE INFORMATION                       | ​ | ​ | ​    | ​ | 46 | ​ | ​ |
| INCORPORATION BY REFERENCE                                | ​ | ​ | ​    | ​ | 47 | ​ | ​ |
| ENFORCEABILITY OF CIVIL LIABILITIES                       | ​ | ​ | ​    | ​ | 48 | ​ | ​ |
| LEGAL MATTERS                                             | ​ | ​ | ​    | ​ | 51 | ​ | ​ |
| EXPERTS                                                   | ​ | ​ | ​    | ​ | 52 | ​ | ​ |

i

TABLE OF CONTENTS

### ABOUT THIS PROSPECTUS
This prospectus is part of an “automatic shelf” registration statement on Form F-3 that we filed with the Securities and Exchange Commission, or SEC, as a “well-known seasoned issuer” as defined in Rule 405 under the Securities Act of 1933, as amended, or the Securities Act, utilizing a “shelf” registration process. Under this shelf registration process, the Selling Shareholders may offer ADSs representing our ordinary shares from time to time in one or more offerings.

To the extent permitted by law, we may also file or authorize one or more prospectus supplements and/or free writing prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement and/or free writing prospectus may also add, update or change information contained in this prospectus. Any statement made in this prospectus will be modified or superseded by any inconsistent statement made in a prospectus supplement and/or free writing prospectus. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or free writing prospectus, you should rely on the prospectus supplement or free writing prospectus, as applicable. Before purchasing any of our securities, you should carefully read the registration statement, including exhibits to the registration statement, this prospectus and any prospectus supplement together with additional information incorporated by reference herein and described under the headings “Where You Can Find More Information” and “Incorporation by Reference.”

When acquiring any securities described in this prospectus, you should rely only on the information provided in this prospectus and in any applicable prospectus supplement and related free writing prospectuses, including the information incorporated by reference. Neither we nor any Selling shareholder, underwriter, dealer or agent